Lexaria Bioscience Unveils $3.6 Million Offering in Strategic Financial Move
KELOWNA, BC – In a noteworthy development that underscores the tireless pursuit of innovation and growth, Lexaria Bioscience Corp. has officially announced a registered direct offering and a concurrent private placement, a strategic financial move poised to significantly impact its operational capabilities. This venture marks a pivotal step for the company, with the transaction slated for closure around February 16, 2024.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
